Bonds & New Issues

Volatility the biggest risk investors face in 2017

Volatility the biggest risk investors face in 2017

Volatility is the biggest pothole in the path to mouthwatering returns, warns Ken Fisher, but interest rate risk, inflation risk and political risk shouldn't be underestimated either.

Here's how inflation could top 4% in 2017

Here's how inflation could top 4% in 2017

Rory McPherson at Psigma reckons inflation may grow much faster than the Bank of England thinks next year. Here, he explains why - and how to position your portfolio for it.

Why markets are wary as European elections loom

markets wary european elections Marine Le Pen 5 star movement populism

December's referendum in Italy and elections in France and Germany next year could have seismic effects on markets, warns David Zahn, who explores how it may play out.

Why stocks are not the only game in town

Why stocks are not the only game in town unloved assets fixed income bonds

In his Monday Morning Call, American money manager Lance Roberts reveals one of the "most unloved" asset classes to own currently.

Brexit: how bond markets have reacted

Brexit EU referendum bond markets reaction gilts quality UK growth EM debt

Violent moves in equities and sterling grabbed headlines, but Brexit has seriously impacted debt markets too. Andre Severino at Nikko Asset Management provides expert analysis.

Why high-yield bonds are shares on steroids

high yield bonds junk stocks equities return loan small companies debt

High-yield, or 'junk', bonds should be handled with care, says Tom Stevenson at Fidelity, but the returns can be stellar - and now could be the time to buy.

Relief as Quindell firms up cash return

Relief as Quindell firms up cash return

After months of waiting, Quindell has finalised details of its 100p cash return to long-suffering shareholders. Further patience is required.

New tech IPO Softcat looks promising

New tech IPO Softcat looks promising

Few fast-growing technology companies have been confident enough to float this year, but Softcat is different. It's doing well and the numbers look good.

22 fund and trusts to see you through stockmarket volatility

22 fund and trusts to see you through stockmarket volatility

Market ructions have thrown up opportunities for value and contrarian investors, while UK smaller companies have avoided the storms.

Double-dose of drug IPOs

Double-dose of drug IPOs

A pair of small drug companies are planning to float in London next month. Here's why.

62002